Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03955991Phase 4Completed
Phase 4, randomised, open-label trial of influenza vaccine in influenza, sponsored by University of Miami. Primary endpoint: Hemagglutination inhibition assay Fold response. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03955991.